The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07272343

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07272343
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07272343. Randomized; no masking; primary purpose treatment. Start 2023-02-10 (actual); primary completion 2026-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
Condition
Type 2 Diabetes Mellitus (T2DM)
Condition
Semaglutide
Condition
Caloric Restriction
Intervention (Drug)
semaglutide
Intervention (Behavioral)
caloric restriction
Lead sponsor
Second Affiliated Hospital of Nanchang University (class: other)

Record details

Record id
cardio:ct-nct07272343
Content hash
05a3879b40fb116adaf7404e0a060ce50b585cba7969fa60c423002d1921f9dd